Douglas Warner
Fortuna: - $ al 31/08/2026
Fortuna: - $ al 31/08/2026
Douglas Warner is currently Chief Medical Officer at Tyra Biosciences, Inc. since 2024.
Formerly, Dr. Warner was Chief Medical Officer at eFFECTOR Therapeutics, Inc. from 2022 to 2024 and Executive Medical Director at Amgen, Inc. Education includes an undergraduate degree from the University of Pennsylvania, an MBA from UCLA Anderson School of Management, and a doctorate from Duke University School of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
TYRA BIOSCIENCE, INC -.--% | 05/05/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Director Técnico/Científico/I+D | 10/09/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 21/06/2024 |
| AMGEN INC. | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University School of Medicine
Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tyra Biosciences, Inc.
Tyra Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cancer treatment drug therapies | Health Technology |
eFFECTOR Therapeutics, Inc.
eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.